-
Recent Posts
- Merck Provides Update on REVEAL Outcomes Study of Anacetrapib
- New drugs to treat anemia of chronic kidney disease
- FDA Endocrinologic and Metabolic Drugs Advisory Committee recommends approval of dapagliflozin for the treatment of type 2 diabetes in adults
- Combined ACE inhibition and angiotensin receptor blockade shows no advantage over single agent RAS inhibition in patients with diabetic nephropathy: VA-Nephron D study
- FDA Advisory Committee recommends against approval of Tolvaptan for polycystic kidney disease
Recent Comments
Archives
Categories
Meta